Phreesia (NYSE:PHR) received a $33.00 price objective from investment analysts at Piper Jaffray Companies in a research note issued on Tuesday, TipRanks reports. The brokerage currently has a “buy” rating on the stock. Piper Jaffray Companies’ price target indicates a potential upside of 28.86% from the stock’s current price.

A number of other brokerages also recently commented on PHR. William Blair assumed coverage on Phreesia in a research report on Monday, August 12th. They set an “outperform” rating for the company. Wells Fargo & Co began coverage on Phreesia in a research note on Monday, August 12th. They set an “outperform” rating and a $23.00 price objective for the company. JPMorgan Chase & Co. assumed coverage on shares of Phreesia in a research note on Tuesday, August 13th. They issued an “overweight” rating and a $33.00 price target for the company. Finally, Chardan Capital initiated coverage on shares of Phreesia in a report on Tuesday, July 23rd. They set a “buy” rating and a $33.00 target price for the company. Five equities research analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and a consensus target price of $30.50.

Phreesia stock traded up $0.29 during mid-day trading on Tuesday, hitting $25.61. 184,581 shares of the stock were exchanged, compared to its average volume of 279,973. The firm’s fifty day moving average price is $26.67. Phreesia has a 12 month low of $22.05 and a 12 month high of $29.38.

In related news, major shareholder Ii L.P. Chv sold 335,767 shares of the company’s stock in a transaction that occurred on Monday, July 22nd. The stock was sold at an average price of $18.00, for a total value of $6,043,806.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Scott Perricelli sold 743,388 shares of the company’s stock in a transaction on Monday, July 22nd. The shares were sold at an average price of $18.00, for a total transaction of $13,380,984.00. The disclosure for this sale can be found here.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments.

Recommended Story: What is the return on assets formula?

Analyst Recommendations for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.